1. Home
  2. CBOE vs NTRA Comparison

CBOE vs NTRA Comparison

Compare CBOE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBOE
  • NTRA
  • Stock Information
  • Founded
  • CBOE 1973
  • NTRA 2003
  • Country
  • CBOE United States
  • NTRA United States
  • Employees
  • CBOE N/A
  • NTRA N/A
  • Industry
  • CBOE Investment Bankers/Brokers/Service
  • NTRA Medical Specialities
  • Sector
  • CBOE Finance
  • NTRA Health Care
  • Exchange
  • CBOE Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • CBOE 21.7B
  • NTRA 22.1B
  • IPO Year
  • CBOE 2010
  • NTRA 2015
  • Fundamental
  • Price
  • CBOE $210.83
  • NTRA $162.31
  • Analyst Decision
  • CBOE Buy
  • NTRA Strong Buy
  • Analyst Count
  • CBOE 12
  • NTRA 17
  • Target Price
  • CBOE $211.25
  • NTRA $165.88
  • AVG Volume (30 Days)
  • CBOE 715.4K
  • NTRA 1.3M
  • Earning Date
  • CBOE 02-07-2025
  • NTRA 02-27-2025
  • Dividend Yield
  • CBOE 1.20%
  • NTRA N/A
  • EPS Growth
  • CBOE 1.12
  • NTRA N/A
  • EPS
  • CBOE 7.21
  • NTRA N/A
  • Revenue
  • CBOE $4,094,500,000.00
  • NTRA $1,531,955,000.00
  • Revenue This Year
  • CBOE N/A
  • NTRA $56.11
  • Revenue Next Year
  • CBOE $4.57
  • NTRA $9.76
  • P/E Ratio
  • CBOE $29.26
  • NTRA N/A
  • Revenue Growth
  • CBOE 8.51
  • NTRA 54.94
  • 52 Week Low
  • CBOE $166.13
  • NTRA $69.91
  • 52 Week High
  • CBOE $221.66
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • CBOE 58.06
  • NTRA 40.88
  • Support Level
  • CBOE $206.45
  • NTRA $168.15
  • Resistance Level
  • CBOE $210.88
  • NTRA $180.41
  • Average True Range (ATR)
  • CBOE 5.41
  • NTRA 7.08
  • MACD
  • CBOE -0.04
  • NTRA -1.24
  • Stochastic Oscillator
  • CBOE 62.10
  • NTRA 14.58

About CBOE Cboe Global Markets Inc.

Cboe global Markets, Inc is a provider of market infrastructure and tradable products, delivers cutting-edge trading, clearing and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive global marketplace, and to providing leading products, technology and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: